Chambers Michael Andrew (CIK 0001932527)

Latest company ownership

SRPT - Sarepta Therapeutics, Inc.

Role: Director

Shares held

75,194

Last filed at

Jun 6, 2022

Confidence Score

50.0

2025Q4

Confidence Score History

2022Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Aug 16, 2024	Aug 20, 2024	Sarepta Therapeutics, Inc.	Director	Buy	100.0	+37,038	14.51%	✗	$5M
Aug 14, 2023	Aug 15, 2023	Sarepta Therapeutics, Inc.	Director	Buy	92.5	+9,979	4.10%	✗	$1.1M
Aug 11, 2023	Aug 14, 2023	Sarepta Therapeutics, Inc.	Director	Buy	100.0	+23,686	10.78%	✗	$2.6M
Aug 10, 2023	Aug 11, 2023	Sarepta Therapeutics, Inc.	Director	Buy	100.0	+34,867	18.86%	✗	$3.7M
Sep 14, 2022	Sep 15, 2022	Sarepta Therapeutics, Inc.	Director	Buy	100.0	+57,100	45.22%	✗	$6M
Aug 19, 2022	Aug 22, 2022	Sarepta Therapeutics, Inc.	Director	Buy	100.0	+46,170	57.64%	✗	$5M